Evidence map›Paper›PMID 36764972›Full record

ReviewEuropean child & adolescent psychiatry2023

Remote assessment of ADHD in children and adolescents: recommendations from the European ADHD Guidelines Group following the clinical experience during the COVID-19 pandemic.

P Santosh, S Cortese, C Hollis, S Bölte, D Daley, D Coghill, M Holtmann, E J S Sonuga-Barke, J Buitelaar, T Banaschewski and 18 more

Open access · hybridAbstract readReview
In one paragraph

Review in European child & adolescent psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 20 institutions in 14 countries.

P SantoshDepartment of Child and Adolescent Psychiatry, Institute of Psychology, Psychiatry and Neuroscience, King's College London, London, UK. paramala.1.santosh@kcl.ac.uk.ORCID http://orcid.org/0000-0003-4830-5893
S CorteseCentre for Innovation in Mental Health, School of Psychology, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, UK.
C HollisSchool of Medicine, National Institute for Health Research (NIHR) MindTech Mental Health MedTech Cooperative, NIHR Nottingham Biomedical Research Centre, Institute of Mental Health, Mental Health and Clinical Neurosciences, University of Nottingham, Nottingham, UK.
S BölteCenter of Neurodevelopmental Disorders (KIND), Centre for Psychiatry Research, Department of Women's and Children's Health, Karolinska Institute and Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden.
D DaleyNTU Psychology, School of Social Science, Nottingham Trent University, Nottingham, UK.
D CoghillDepartments of Paediatrics and Psychiatry, University of Melbourne, Melbourne, VIC, Australia.
M HoltmannLWL-University Hospital for Child and Adolescent Psychiatry, Ruhr University, Bochum, Germany.
E J S Sonuga-BarkeDepartment of Child and Adolescent Psychiatry, Institute of Psychology, Psychiatry and Neuroscience, King's College London, London, UK.
J BuitelaarDepartment of Cognitive Neuroscience, Donders Institute for Brain, Cognition and BehaviourRadboudumc, Nijmegen, The Netherlands.
T BanaschewskiDepartment of Child and Adolescent Psychiatry and Psychotherapy, Medical Faculty, Central Institute of Mental Health, Mannheim/Heidelberg University, Mannheim, Germany.
A StringarisDivisions of Psychiatry and Psychology and Language Sciences, University College London, London, UK.
M DöpfnerDepartment of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany.
S Van der OordClinical Psychology, KU Leuven, Louvain, Belgium.
S CarucciDepartment of Biomedical Sciences, Sect. Neuroscience and Clinical Pharmacology, University of Cagliari, Cagliari, Italy.
D BrandeisDepartment of Child and Adolescent Psychiatry and Psychotherapy, Medical Faculty, Central Institute of Mental Health, Mannheim/Heidelberg University, Mannheim, Germany.
P NagyBethesda Children's Hospital, Budapest, Hungary.
M FerrinBarnet, Enfield and Haringey NHS Trust, ReCognition Health, London, UK.
D BaeyensClinical Psychology, KU Leuven, Louvain, Belgium.
B J van den HoofdakkerDepartment of Child and Adolescent Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
D Purper-OuakilUnit of Child and Adolescent Psychiatry (MPEA1), CHU Montpellier-Saint Eloi Hospital, University of Montpellier, 80 Avenue Augustin Fliche, 34000, Montpellier, France.
A Ramos-QuirogaVall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.
M RomanosDepartment of Child and Adolescent, Center of Mental Health, University Hospital of Wurzburg, Wurzburg, Germany.
C A SoutulloLouis A Faillace Department of Psychiatry and Behavioral Science, University of Texas (UT) Health, Houston, TX, USA.
A ThaparDivision of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Wolfson Centre for Young People's Mental Health, Cardiff University School of Medicine, Wales, UK.
I C K WongDepartment of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong, SAR, China.
A ZuddasDepartment of Biomedical Sciences, Sect. Neuroscience and Clinical Pharmacology, University of Cagliari, Cagliari, Italy.
C GaleraUniversity of Bordeaux, Bordeaux, France.
E SimonoffDepartment of Child and Adolescent Psychiatry, Institute of Psychology, Psychiatry and Neuroscience, King's College London, London, UK.
King's College London · GBKU Leuven · BEUniversity of Cagliari · ITUniversity of Nottingham · GBBarnet Enfield and Haringey Mental Health Trust · GBCardiff University · GBChinese University of Hong Kong · HKCurtin University · AUHeidelberg University · DEInserm · FRLWL-Universitätsklinikum Bochum · DENational and Kapodistrian University of Athens · GRNottingham Trent University · GBRadboud University Nijmegen · NLRoyal Children's Hospital · AUThe University of Texas Health Science Center at Houston · USUniversitat Autònoma de Barcelona · ESUniversitätsklinikum Würzburg · DEUniversité de Bordeaux · FRUniversity Medical Center Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic led ADHD services to modify the clinical practice to reduce in-person contact as much as possible to minimise viral spread. This had far-reaching effects on day-to-day clinical practice as remote assessments were widely adopted. Despite the attenuation of the acute threat from COVID, many clinical services are retaining some remote practices. The lack of clear evidence-based guidance about the most appropriate way to conduct remote assessments meant that these changes were typically implemented in a localised, ad hoc, and un-coordinated way. Here, the European ADHD Guidelines Group (EAGG) discusses the strengths and weaknesses of remote assessment methods of children and adolescents with ADHD in a narrative review based on available data and expert opinions to highlight key recommendations for future studies and clinical practice. We conclude that going forward, despite remote working in clinical services functioning adequately during the pandemic, all required components of ADHD assessment should still be completed following national/international guidelines; however, the process may need adaptation. Social restrictions, including changes in education provision, can either mask or exacerbate features associated with ADHD and therefore assessment should carefully chart symptom profile and impairment prior to, as well as during an ongoing pandemic. While remote assessments are valuable in allowing clinical services to continue despite restrictions and may have benefits for routine care in the post-pandemic world, particular attention must be paid to those who may be at high risk but not be able to use/access remote technologies and prioritize these groups for conventional face-to-face assessments.

Indexed as

Attention Deficit Disorder with HyperactivityCOVID-19AdolescentChildDelivery of Health CareHumansPandemicsADHDAdolescentsChildrenCOVID-19European ADHD Guidelines Group (EAGG)PandemicRemote assessment

Identifiers

PMID36764972
PMCPMC9918404
OpenAlexW4320032879

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.